| Literature DB >> 18535582 |
Mark Gudiksen1, Edd Fleming, Laura Furstenthal, Philip Ma.
Abstract
Specialty pharmaceuticals have become increasingly important in the global pharmaceutical landscape. Numerous large pharmaceutical companies are moving towards developing therapies for specialty markets, which are attractive owing to factors including the established commercial track record and lower commercial infrastructure costs. In this article, we analyse the key drivers of commercial success and failure for specialty pharmaceuticals.Mesh：
Substances：
Year: 2008 PMID： 18535582 DOI： 10.1038/nrd2594
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694